Table 2.
CMR characteristics in the study population
| |
Baseline |
Sixmonths |
P |
|---|---|---|---|
| N = 27 | N = 27 | ||
| LVEF (%) |
61.5±14.5 |
65.1±7.2 |
0.08 |
| LVEDV (ml) |
151.4±50.1 |
151.7±38.9 |
0.97 |
| LVEDVi (ml/m2) |
87.2±30.14 |
86.4±22.3 |
0.84 |
| LVESV (ml) |
61.1±44.6 |
53.4±19.2 |
0.16 |
| LVESVi (ml/m2) |
35.29±24.7 |
30.5±11.5 |
0.15 |
| LVM (g) |
148.2±44.6 |
122.5±34.8 |
<0.001 |
| LVMi (g/m2) |
84.5±25.2 |
69.4±18.4 |
<0.001 |
| Stroke volume (ml) |
89.2±22 |
94.7±26.5 |
0.25 |
| CardiacOutput (L/min) |
5.9±1.4 |
5.9±1.3 |
0.98 |
| Mass/Volume ratio | 0.99±2 | 0.82±0.18 | 0.001 |
CMR cardiovascular magnetic resonance; LVEDVi indexed left ventricular end diastolic volume; LVESVi indexed left ventricular end systolic volume; LVMi indexed left ventricular mass; LVEDV left ventricular end diastolic volume; LVEF left ventricular ejection fraction; LVM left ventricular mass; LVESV left ventricular end systolic volume.